Charles River Laboratories Lifts Forecast Amid Strategic Shift and Investor Pressure
A notable surge in the share price of Charles River Laboratories was observed on Wednesday, following an upward revision of the company’s annual profit forecast. The revision had been attributed to an expected rise in demand for contract drug research services, particularly in the area of discovery and safety assessment. The development came at a […]